Novo Nordisk A/S’s blockbuster shot Ozempic was linked to an increased risk of a rare form of vision loss in a study that backs up Harvard University research published earlier this year.

For the first time in a decade, obesity in the US is declining — and a new study suggests it’s because of wildly popular medications such as Ozempic. The number of obese Americans has been ...